Cerebral ischemia-
reperfusion injury (CIRI) is associated with a poor neurological prognosis in patients who have experienced
cardiac arrest (CA) and
cardiopulmonary resuscitation (
CPR). The aim of the current study was to investigate the potential role of a
calpain inhibitor in CIRI using a rat model of CA. CA was induced in adult male Sprague-Dawley rats, and
MDL28170 (a
calpain inhibitor) was administered to the rats within 30 min after the return of spontaneous circulation. Differences between groups were evaluated by measuring survival rate,
CPR duration and neurological deficit score.
Hematoxylin-
eosin staining and Nissl staining were performed to assess cerebral injury, and microstructure and autophagy were assessed by transmission electron microscopy. The levels of calpain-1, calpain-2,
calpastatin,
interleukin (IL)-1β,
tumor necrosis factor (TNF)-α, P62,
beclin-1 and LC3 in the brain tissues were determined using western blotting and double immunofluorescence staining. There was no significant difference in
CPR duration or survival rate among the groups. At 24 h after
CPR, the CA group demonstrated damaged tissue morphology; decreased neurological deficit scores, and P62 expression; and upregulated calpain-2, IL-1βp17, TNF-α,
beclin-1 and LC3 levels in the cortex. However,
MDL28170 improved neuronal function and suppressed
inflammation and autophagy by inhibiting calpain-2 level, but there were no differences in the calpain-1 and
calpastatin levels. These results suggest that calpain-2,
inflammation and autophagy are involved in CA-induced CIRI.
MDL28170 inhibited calpain-2 expression,
inflammation and autophagy, which suggests its potential efficacy in treating post-CA nerve damage.